SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -37.5% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $8,000 | +14.3% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $7,000 | -50.0% | 3,000 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $14,000 | -39.1% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $23,000 | -53.1% | 3,000 | -40.7% | 0.00% | -55.6% |
| Q2 2021 | $49,000 | +16.7% | 5,059 | 0.0% | 0.01% | +12.5% |
| Q1 2021 | $42,000 | -23.6% | 5,059 | -37.2% | 0.01% | -33.3% |
| Q4 2020 | $55,000 | -38.9% | 8,059 | 0.0% | 0.01% | -42.9% |
| Q3 2020 | $90,000 | +190.3% | 8,059 | +65.5% | 0.02% | +200.0% |
| Q2 2020 | $31,000 | +287.5% | 4,870 | +16.0% | 0.01% | +250.0% |
| Q1 2020 | $8,000 | -27.3% | 4,200 | +31.2% | 0.00% | -33.3% |
| Q4 2019 | $11,000 | +57.1% | 3,200 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $7,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |